4107 — ISE Chemicals Balance Sheet
0.000.00%
- ¥201bn
- ¥192bn
- ¥33bn
- 94
- 16
- 87
- 77
Annual balance sheet for ISE Chemicals, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,134 | 6,276 | 8,387 | 9,720 | 8,687 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10,789 | 8,048 | 6,149 | 6,691 | 8,919 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17,809 | 18,360 | 20,413 | 24,141 | 28,085 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,931 | 13,910 | 14,485 | 14,702 | 15,853 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 31,069 | 33,415 | 36,146 | 40,082 | 45,251 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,811 | 4,615 | 5,215 | 6,806 | 8,189 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,389 | 6,285 | 6,926 | 8,190 | 9,682 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 25,680 | 27,130 | 29,220 | 31,892 | 35,569 |
| Total Liabilities & Shareholders' Equity | 31,069 | 33,415 | 36,146 | 40,082 | 45,251 |
| Total Common Shares Outstanding |